WHO-GMP Partner Network
Global Trade

Exporting Generic Medicines to Africa and LATAM: A Practical Checklist

Exporting Generic Medicines to Africa and LATAM: A Practical Checklist

Africa and Latin America are among the most important destinations for Indian generic medicines. Growing populations, expanding health coverage and strong demand for affordable quality medicines create real opportunities. Yet each country has its own regulator, registration process, labelling rules and import requirements. Preparation is the difference between a smooth launch and a stalled shipment.

This practical checklist walks through the stages of entering these markets, from choosing countries to receiving payment.

Step 1: Market Selection

  1. Assess disease burden and demand for your therapeutic segments.
  2. Review the regulatory pathway, fees and typical registration timelines.
  3. Study competition and price levels in public and private channels.
  4. Identify reliable local distributors or licence holders.
  5. Check whether tenders or private pharmacy sales will drive volumes.

Start with a small number of focus markets rather than spreading effort thinly. Countries with predictable regulatory processes and strong distributor partners usually deliver faster results.

Step 2: Choose the Right Local Partner

In most markets the local partner holds or manages the registration, imports the product and handles distribution. A good partner brings regulatory experience, warehouse and distribution capability, and relationships with pharmacies, hospitals or tender bodies. Check references, financial strength and portfolio fit before signing an agreement, and define responsibilities for registration, marketing and pharmacovigilance clearly.

Step 3: Registration Essentials

  • CTD, ACTD or country specific dossier
  • Stability data for the relevant climatic zone, often Zone IVb
  • Bioequivalence data where required
  • COPP, GMP certificate and manufacturing licence
  • Samples, reference standards and registration fees
  • Local language labelling and patient information leaflets

Some regulators also conduct or rely on GMP inspections of the manufacturing site. Keep inspection readiness high, and check whether reliance mechanisms or regional joint assessments can shorten timelines.

Step 4: Pricing and Commercial Terms

Price competitively but realistically. Include registration costs, samples, freight, insurance, local agent commissions and payment risk in your calculations. Agree incoterms clearly, as CIF and FOB shipments shift costs and risks differently between buyer and seller.

Step 5: Export Documentation

Most shipments require a certificate of pharmaceutical product, GMP certificate, certificate of analysis, commercial invoice, packing list and certificate of origin. Some countries also require pre-shipment inspection, a certificate of conformity or legalisation of documents through the chamber of commerce and embassy.

Region Common extra requirements
West Africa Pre-shipment inspection and destination registration numbers on packs
East Africa Import permits and product registration verification at entry
Latin America Local language labels and legalised or apostilled documents

Requirements change over time, so confirm current rules with your partner for each shipment.

Step 6: Logistics

Choose between sea and air freight based on product value, shelf life and urgency. Confirm temperature requirements, use data loggers where needed, and ensure that remaining shelf life on arrival meets buyer and regulator expectations. Work with freight forwarders experienced in pharmaceutical cargo.

Step 7: Payment and Risk Management

For new partners, secure payment terms such as advance payment or confirmed letters of credit reduce risk. Export credit insurance can protect receivables as volumes grow. Monitor currency movements, as local currency depreciation can affect a partner’s ability to pay.

A first shipment that arrives complete, compliant and on time builds more trust than any sales presentation.

Step 8: After Sales and Pharmacovigilance

Support your partner with product training, marketing materials and prompt handling of complaints. Establish pharmacovigilance responsibilities in writing, including how adverse events are reported to the regulator and to the manufacturer.

Choosing Products for Your First Wave

Select a focused first portfolio that matches market demand and your strengths. Essential medicines with established use, stable formulations and existing dossiers usually register faster. Products with strong local competition may still succeed if you can offer better quality consistency, supply reliability or pack formats suited to the market.

Protecting Against Falsified Medicines

Many regulators are strengthening measures against substandard and falsified medicines, including serialisation, track and trace requirements and security features on packs. Check current packaging and coding requirements in each market, and work with partners to monitor the market for counterfeits of your brands.

Building Long Term Relationships

Regular visits, joint business planning and transparent communication about supply timelines turn distributors into long term partners. Share forecasts, plan production together and review performance quarterly.

Understanding Public and Private Channels

In many African and Latin American markets, medicines reach patients through two very different channels. Public sector supply is driven by national tenders, central medical stores and donor funded programmes, where price, registration and reliable delivery decide success. Private sector supply flows through importers, wholesalers, pharmacies and private hospitals, where brand recognition, availability and relationships with prescribers matter more.

Decide early which channel you are targeting for each product, because it affects pack sizes, labelling, pricing and the type of partner you need. Some companies use tender business to build volumes and presence, then develop branded private market sales once registrations and supply reliability are established.

First Shipment Checklist

  • Registration approved and registration number confirmed for the pack
  • Artwork approved in the local language with required statements
  • All certificates valid beyond the expected arrival date
  • Legalisation and pre-shipment inspection completed where required
  • Remaining shelf life on arrival meets buyer and regulator expectations
  • Payment terms and incoterms confirmed in writing

Reviewing this list with your partner before dispatch prevents most first shipment problems.

Once the first shipment is received successfully, hold a short review with your partner covering what worked well, any delays at customs or the warehouse, and feedback from customers. Apply these lessons to the next order and to the next market. Over time, a disciplined review habit turns market entry from a series of one off projects into a repeatable export playbook that scales across regions and product lines. Document each step, template and contact in a shared playbook so that new team members and new partners can follow the same proven process without starting from zero.

Key takeaway

Registration is the longest step. Start dossier work early, choose strong local partners, and treat documentation and logistics as part of the product itself.

Zanax Healthcare supports exporters and importers with market selection, registration dossiers, documentation, logistics and ongoing supply to Africa, Latin America and other emerging markets.

Frequently Asked Questions

Do I need product registration before exporting to Africa?

In most countries, yes. Medicines generally need to be registered with the national regulator before they can be imported and sold, although some tender or emergency programmes follow special procedures.

How long does registration take in these markets?

Timelines vary widely by country and product, from several months to a few years. Starting dossier work early and responding quickly to queries helps reduce delays.

Are regional registration schemes available in Africa?

Regional harmonisation initiatives exist, such as joint assessment programmes in some regional economic communities, and they can reduce duplication. Check eligibility for your products and markets.

What payment terms are common for new partners?

Advance payment or confirmed letters of credit are common with new partners, moving to more flexible terms as trust and trading history develop.

Is Spanish or Portuguese labelling required in Latin America?

Most Latin American regulators require labels and leaflets in the local language, Spanish in most countries and Portuguese in Brazil, following the approved registration.

admin

Part of the Zanax Healthcare editorial team, sharing practical insights on pharma regulation, manufacturing and global trade.

Keep Reading

Related Articles

Let's Work Together

Planning a Pharma Project or Looking for a Reliable Supply Partner?

Share your requirement and our specialists will get back within one business day with a clear plan, timeline and quote.